CompletedNot Applicable

Impact of Level and Quality of Immunosuppression on Onset and Pattern of Cardiac Allograft Vasculopathy Evaluated by OCT

Germany100 participantsStarted 2016-07

Plain-language summary

The aim of this study is to use the high resolution of optical coherence tomography to assess the prevalence of different types of cardiac allograft vasculopathy (CAV) in cardiac transplanted patients and correlate those results with the level of immunosuppression

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients after cardiac transplantation undergoing planed routine angiographic examination and intracoronary imaging. * Written informed consent Exclusion Criteria: * Age \< 18 years old * Hemodynamic and/or electric instability * Chronic kidney failure with glomerular filtration rate \< 30 ml/min * Pregnant or breastfeeding women * Incapacity of providing informed consent * If in the investigator's opinion the patient has (a) co-morbid condition(s) that could limit the patient's ability to participate in the study or impact the scientific integrity of the study * Any contraindication to intracoronary imaging

What they're measuring

CAV patterns

Timeframe: 2 years

Trial details

NCT IDNCT03079791

SponsorLMU Klinikum

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-01

View on ClinicalTrials.gov More Transplant; Failure, Heart trials